Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Epstein-Barr virus: an important vaccine target for cancer prevention.
Helminth therapy and multiple sclerosis.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Multiple sclerosis and breast cancer.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.
Autoimmune myelopathies.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Tysabri prescribing information
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
In vitro modeling of central nervous system myelination and remyelination.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Pages